Birgit M. Wollmann

Primary Human Hepatocyte Spheroids as an In Vitro Tool for Investigating Drug Compounds with Low Hepatic Clearance

Julia Riede, Birgit M. Wollmann, Espen Molden et al. · Drug Metabolism and Disposition · 2021 · 47 citations · Full text

Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker

Kristine Hole, Birgit M. Wollmann, Camilla Nguyen et al. · Therapeutic Drug Monitoring · 2018 · 37 citations

Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia

Robert L. Smith, Birgit M. Wollmann, Lennart Kyllesø et al. · Journal of Clinical Psychopharmacology · 2021 · 32 citations

Short‐ and long‐term effects of body weight loss following calorie restriction and gastric bypass on CYP3A‐activity – a non‐randomized three‐armed controlled trial

Kine Eide Kvitne, Ida Robertsen, Eva Skovlund et al. · Clinical and Translational Science · 2021 · 30 citations · Full text

Associations between Cytokine Levels and CYP3A4 Phenotype in Patients with Rheumatoid Arthritis

Birgit M. Wollmann, Silje Watterdal Syversen, Maria Vistnes et al. · Drug Metabolism and Disposition · 2018 · 21 citations · Full text